IL17A and congenital rubella syndrome: The current endotypic classification of CRS defines subgroups according to the underlying immune mechanisms, such as T1 (IFN-γ-driven), T2 (IL-4/13, IL-5 or IgE driven) or T3 (IL-17-driven) (53, 55).